113 related articles for article (PubMed ID: 16678126)
1. Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.
Cohen S; Lahav-Baratz S; Ciechanover A
Biochem Biophys Res Commun; 2006 Jun; 345(1):7-13. PubMed ID: 16678126
[TBL] [Abstract][Full Text] [Related]
2. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Mol Cell; 2009 Feb; 33(4):496-504. PubMed ID: 19250910
[TBL] [Abstract][Full Text] [Related]
3. Structural motifs involved in ubiquitin-mediated processing of the NF-kappaB precursor p105: roles of the glycine-rich region and a downstream ubiquitination domain.
Orian A; Schwartz AL; Israël A; Whiteside S; Kahana C; Ciechanover A
Mol Cell Biol; 1999 May; 19(5):3664-73. PubMed ID: 10207090
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of ubiquitin-mediated, limited processing of the NF-kappaB1 precursor protein p105.
Ciechanover A; Gonen H; Bercovich B; Cohen S; Fajerman I; Israël A; Mercurio F; Kahana C; Schwartz AL; Iwai K; Orian A
Biochimie; 2001; 83(3-4):341-9. PubMed ID: 11295495
[TBL] [Abstract][Full Text] [Related]
5. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
[TBL] [Abstract][Full Text] [Related]
6. ABIN-1 negatively regulates NF-kappaB by inhibiting processing of the p105 precursor.
Cohen S; Ciechanover A; Kravtsova-Ivantsiv Y; Lapid D; Lahav-Baratz S
Biochem Biophys Res Commun; 2009 Nov; 389(2):205-10. PubMed ID: 19695220
[TBL] [Abstract][Full Text] [Related]
7. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner.
Moorthy AK; Savinova OV; Ho JQ; Wang VY; Vu D; Ghosh G
EMBO J; 2006 May; 25(9):1945-56. PubMed ID: 16619030
[TBL] [Abstract][Full Text] [Related]
8. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target.
Shabek N; Iwai K; Ciechanover A
Biochem Biophys Res Commun; 2007 Nov; 363(2):425-31. PubMed ID: 17870054
[TBL] [Abstract][Full Text] [Related]
10. The role of ubiquitin in NF-kappaB regulatory pathways.
Skaug B; Jiang X; Chen ZJ
Annu Rev Biochem; 2009; 78():769-96. PubMed ID: 19489733
[TBL] [Abstract][Full Text] [Related]
11. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
[TBL] [Abstract][Full Text] [Related]
12. The generation of nfkb2 p52: mechanism and efficiency.
Heusch M; Lin L; Geleziunas R; Greene WC
Oncogene; 1999 Nov; 18(46):6201-8. PubMed ID: 10597218
[TBL] [Abstract][Full Text] [Related]
13. Leucine suppresses myofibrillar proteolysis by down-regulating ubiquitin-proteasome pathway in chick skeletal muscles.
Nakashima K; Ishida A; Yamazaki M; Abe H
Biochem Biophys Res Commun; 2005 Oct; 336(2):660-6. PubMed ID: 16153608
[TBL] [Abstract][Full Text] [Related]
14. A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.
Lin L; Ghosh S
Mol Cell Biol; 1996 May; 16(5):2248-54. PubMed ID: 8628291
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.
Gao K; Dai DL; Martinka M; Li G
Cancer Res; 2006 Sep; 66(17):8382-8. PubMed ID: 16951147
[TBL] [Abstract][Full Text] [Related]
16. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
[TBL] [Abstract][Full Text] [Related]
17. Processing of p105 is inhibited by docking of p50 active subunits to the ankyrin repeat domain, and inhibition is alleviated by signaling via the carboxyl-terminal phosphorylation/ ubiquitin-ligase binding domain.
Cohen S; Orian A; Ciechanover A
J Biol Chem; 2001 Jul; 276(29):26769-76. PubMed ID: 11350967
[TBL] [Abstract][Full Text] [Related]
18. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
Fuchs O; Neuwirtová R
Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine dithiocarbamate and zinc inhibit proteasome-dependent proteolysis.
Kim I; Kim CH; Kim JH; Lee J; Choi JJ; Chen ZA; Lee MG; Chung KC; Hsu CY; Ahn YS
Exp Cell Res; 2004 Aug; 298(1):229-38. PubMed ID: 15242777
[TBL] [Abstract][Full Text] [Related]
20. Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor.
Kravtsova-Ivantsiv Y; Cohen S; Ciechanover A
Adv Exp Med Biol; 2011; 691():95-106. PubMed ID: 21153313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
